Loading…
Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases
Saved in:
Published in: | Clinical genitourinary cancer 2019-06, Vol.17 (3), p.e612-e617 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c426t-d32a99ad00ed0640f12f1653aa98557f448dd0bdce4c7c30321b6185d913d373 |
---|---|
cites | cdi_FETCH-LOGICAL-c426t-d32a99ad00ed0640f12f1653aa98557f448dd0bdce4c7c30321b6185d913d373 |
container_end_page | e617 |
container_issue | 3 |
container_start_page | e612 |
container_title | Clinical genitourinary cancer |
container_volume | 17 |
creator | Dionisi, Valeria Bellarosa, Chiara Cardano, Raffaele Rizzini, Elisa Lodi Ghedini, Pietro Morganti, Alessio Giuseppe Fanti, Stefano Monari, Fabio |
description | |
doi_str_mv | 10.1016/j.clgc.2019.03.002 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2205413140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1558767319300825</els_id><sourcerecordid>2205413140</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-d32a99ad00ed0640f12f1653aa98557f448dd0bdce4c7c30321b6185d913d373</originalsourceid><addsrcrecordid>eNp9kE1P3DAURa2qqHz1D3RRedlN0mc7dpKqGzRtKQgJhEBIbCyP_dLxKBMPtkPFvyfRAEtW7y3OvdI9hHxhUDJg6vu6tP0_W3JgbQmiBOAfyAFrRVOAavjH6ZeyKWpVi31ymNIaoJKshk9kX0ArFbTqgOTbhDR09No4P24KzgX95e2qD9E7pH6gVyZ7HHKidz6v6GXKGAa0MSSf5lxeIT03_-nZ4EaLji6f6H3o0cUweEtPrHc_6DVuQ8wzzenCJEzHZK8zfcLPL_eI3Pz5fbP4W1xcnp4tTi4KW3GVCye4aVvjANCBqqBjvGNKCmPaRsq6q6rGOVg6i5WtrQDB2VKxRrqWCSdqcUS-7Wq3MTyMmLLe-GSx782AYUyac5AVE6yCCeU7dF6WInZ6G_3GxCfNQM-y9VrPsvUsW4PQk-wp9PWlf1xu0L1FXu1OwM8dgNPIR49RJzvJnDz5iDZrF_x7_c-plY6J</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2205413140</pqid></control><display><type>article</type><title>Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Dionisi, Valeria ; Bellarosa, Chiara ; Cardano, Raffaele ; Rizzini, Elisa Lodi ; Ghedini, Pietro ; Morganti, Alessio Giuseppe ; Fanti, Stefano ; Monari, Fabio</creator><creatorcontrib>Dionisi, Valeria ; Bellarosa, Chiara ; Cardano, Raffaele ; Rizzini, Elisa Lodi ; Ghedini, Pietro ; Morganti, Alessio Giuseppe ; Fanti, Stefano ; Monari, Fabio</creatorcontrib><identifier>ISSN: 1558-7673</identifier><identifier>EISSN: 1938-0682</identifier><identifier>DOI: 10.1016/j.clgc.2019.03.002</identifier><identifier>PMID: 30956096</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Bisphosphonate therapy ; Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology ; Bone metastases ; Bone Neoplasms - drug therapy ; Bone Neoplasms - secondary ; Castration-resistant prostate cancer ; Humans ; Jaw necrosis ; Male ; Prostatic Neoplasms, Castration-Resistant - drug therapy ; Ra-223 ; Radioisotopes - administration & dosage ; Radioisotopes - therapeutic use ; Radium - administration & dosage ; Radium - therapeutic use ; Treatment Outcome ; Zoledronic Acid - adverse effects</subject><ispartof>Clinical genitourinary cancer, 2019-06, Vol.17 (3), p.e612-e617</ispartof><rights>2019 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-d32a99ad00ed0640f12f1653aa98557f448dd0bdce4c7c30321b6185d913d373</citedby><cites>FETCH-LOGICAL-c426t-d32a99ad00ed0640f12f1653aa98557f448dd0bdce4c7c30321b6185d913d373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30956096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dionisi, Valeria</creatorcontrib><creatorcontrib>Bellarosa, Chiara</creatorcontrib><creatorcontrib>Cardano, Raffaele</creatorcontrib><creatorcontrib>Rizzini, Elisa Lodi</creatorcontrib><creatorcontrib>Ghedini, Pietro</creatorcontrib><creatorcontrib>Morganti, Alessio Giuseppe</creatorcontrib><creatorcontrib>Fanti, Stefano</creatorcontrib><creatorcontrib>Monari, Fabio</creatorcontrib><title>Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases</title><title>Clinical genitourinary cancer</title><addtitle>Clin Genitourin Cancer</addtitle><subject>Aged</subject><subject>Bisphosphonate therapy</subject><subject>Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology</subject><subject>Bone metastases</subject><subject>Bone Neoplasms - drug therapy</subject><subject>Bone Neoplasms - secondary</subject><subject>Castration-resistant prostate cancer</subject><subject>Humans</subject><subject>Jaw necrosis</subject><subject>Male</subject><subject>Prostatic Neoplasms, Castration-Resistant - drug therapy</subject><subject>Ra-223</subject><subject>Radioisotopes - administration & dosage</subject><subject>Radioisotopes - therapeutic use</subject><subject>Radium - administration & dosage</subject><subject>Radium - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Zoledronic Acid - adverse effects</subject><issn>1558-7673</issn><issn>1938-0682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1P3DAURa2qqHz1D3RRedlN0mc7dpKqGzRtKQgJhEBIbCyP_dLxKBMPtkPFvyfRAEtW7y3OvdI9hHxhUDJg6vu6tP0_W3JgbQmiBOAfyAFrRVOAavjH6ZeyKWpVi31ymNIaoJKshk9kX0ArFbTqgOTbhDR09No4P24KzgX95e2qD9E7pH6gVyZ7HHKidz6v6GXKGAa0MSSf5lxeIT03_-nZ4EaLji6f6H3o0cUweEtPrHc_6DVuQ8wzzenCJEzHZK8zfcLPL_eI3Pz5fbP4W1xcnp4tTi4KW3GVCye4aVvjANCBqqBjvGNKCmPaRsq6q6rGOVg6i5WtrQDB2VKxRrqWCSdqcUS-7Wq3MTyMmLLe-GSx782AYUyac5AVE6yCCeU7dF6WInZ6G_3GxCfNQM-y9VrPsvUsW4PQk-wp9PWlf1xu0L1FXu1OwM8dgNPIR49RJzvJnDz5iDZrF_x7_c-plY6J</recordid><startdate>20190601</startdate><enddate>20190601</enddate><creator>Dionisi, Valeria</creator><creator>Bellarosa, Chiara</creator><creator>Cardano, Raffaele</creator><creator>Rizzini, Elisa Lodi</creator><creator>Ghedini, Pietro</creator><creator>Morganti, Alessio Giuseppe</creator><creator>Fanti, Stefano</creator><creator>Monari, Fabio</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190601</creationdate><title>Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases</title><author>Dionisi, Valeria ; Bellarosa, Chiara ; Cardano, Raffaele ; Rizzini, Elisa Lodi ; Ghedini, Pietro ; Morganti, Alessio Giuseppe ; Fanti, Stefano ; Monari, Fabio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-d32a99ad00ed0640f12f1653aa98557f448dd0bdce4c7c30321b6185d913d373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Bisphosphonate therapy</topic><topic>Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology</topic><topic>Bone metastases</topic><topic>Bone Neoplasms - drug therapy</topic><topic>Bone Neoplasms - secondary</topic><topic>Castration-resistant prostate cancer</topic><topic>Humans</topic><topic>Jaw necrosis</topic><topic>Male</topic><topic>Prostatic Neoplasms, Castration-Resistant - drug therapy</topic><topic>Ra-223</topic><topic>Radioisotopes - administration & dosage</topic><topic>Radioisotopes - therapeutic use</topic><topic>Radium - administration & dosage</topic><topic>Radium - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Zoledronic Acid - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dionisi, Valeria</creatorcontrib><creatorcontrib>Bellarosa, Chiara</creatorcontrib><creatorcontrib>Cardano, Raffaele</creatorcontrib><creatorcontrib>Rizzini, Elisa Lodi</creatorcontrib><creatorcontrib>Ghedini, Pietro</creatorcontrib><creatorcontrib>Morganti, Alessio Giuseppe</creatorcontrib><creatorcontrib>Fanti, Stefano</creatorcontrib><creatorcontrib>Monari, Fabio</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical genitourinary cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dionisi, Valeria</au><au>Bellarosa, Chiara</au><au>Cardano, Raffaele</au><au>Rizzini, Elisa Lodi</au><au>Ghedini, Pietro</au><au>Morganti, Alessio Giuseppe</au><au>Fanti, Stefano</au><au>Monari, Fabio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases</atitle><jtitle>Clinical genitourinary cancer</jtitle><addtitle>Clin Genitourin Cancer</addtitle><date>2019-06-01</date><risdate>2019</risdate><volume>17</volume><issue>3</issue><spage>e612</spage><epage>e617</epage><pages>e612-e617</pages><issn>1558-7673</issn><eissn>1938-0682</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30956096</pmid><doi>10.1016/j.clgc.2019.03.002</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1558-7673 |
ispartof | Clinical genitourinary cancer, 2019-06, Vol.17 (3), p.e612-e617 |
issn | 1558-7673 1938-0682 |
language | eng |
recordid | cdi_proquest_miscellaneous_2205413140 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Aged Bisphosphonate therapy Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology Bone metastases Bone Neoplasms - drug therapy Bone Neoplasms - secondary Castration-resistant prostate cancer Humans Jaw necrosis Male Prostatic Neoplasms, Castration-Resistant - drug therapy Ra-223 Radioisotopes - administration & dosage Radioisotopes - therapeutic use Radium - administration & dosage Radium - therapeutic use Treatment Outcome Zoledronic Acid - adverse effects |
title | Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A25%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20Radium-223%20Dichloride%20in%20Patients%20With%20Osteonecrosis%20of%20the%20Jaw%20Induced%20by%20Zoledronic%20Acid:%20Report%20of%202%20Cases&rft.jtitle=Clinical%20genitourinary%20cancer&rft.au=Dionisi,%20Valeria&rft.date=2019-06-01&rft.volume=17&rft.issue=3&rft.spage=e612&rft.epage=e617&rft.pages=e612-e617&rft.issn=1558-7673&rft.eissn=1938-0682&rft_id=info:doi/10.1016/j.clgc.2019.03.002&rft_dat=%3Cproquest_cross%3E2205413140%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c426t-d32a99ad00ed0640f12f1653aa98557f448dd0bdce4c7c30321b6185d913d373%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2205413140&rft_id=info:pmid/30956096&rfr_iscdi=true |